Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2021 | BIPOC underrepresentation in clinical trials

Gabrielle Rocque, MD, University of Alabama at Birmingham, Birmingham, AL, discusses the challenges of treating black and indigenous patients, and patients of colour, who are underrepresented in clinical trials. Previous research has suggested that these populations have a similar interest level as patient populations who are well-represented, but that BIPOC patients are offered clinical trials less often. Logistical issues and access to care are additional challenges. The underrepresentation makes it harder for care providers to give patients information about what to expect from various treatment options. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.